Sponsors

Tepnel extends licence agreement with Luminex

  •  

Tepnel Life Sciences has agreed an extension of the licence with Luminex for access to the Luminex xMAP platform. The Luminex xMAP technology is incorporated in TepnelÆs innovative molecular diagnostics products.

Tepnel’s LifeMatch products are used for the measurement and detection of human leucocyte antigen (HLA) markers, which are used in the field of bone marrow and solid organ transplantation. These products permit the rapid analysis of a donor’s HLA type to determine if they are a potential match to a patient awaiting transplantation.

Tepnel develops highly multiplexed DNAand protein-based assays and user-friendly software for its successful LifeMatch product line. The Luminex technology allows Tepnel Lifecodes users to analyse up to 100 simultaneous reactions on a single patient sample.

www.tepnel.com

Other News

Advice accepted on spring 2026 COVID-19 vaccination programme

News

Dec 22, 2025
Blood test could spare men with advanced prostate cancer from futile chemotherapy

News

Dec 22, 2025
BD to advance immunotherapy through flow cytometry at University of Pennsylvania

News

Dec 22, 2025
National-scale molecular avian influenza surveillance deployed across Egypt

News

Dec 22, 2025
Blood test part of landmark study on Alzheimer's prevalence

News

Dec 19, 2025
MHRA seeks input on AI regulation

News

Dec 18, 2025
The latest Biomedical Science Industry Handbook is available now!

News

Dec 16, 2025
ALZpath and Siemens Healthineers collaborate on blood-based Alzheimer's diagnostics

News

Dec 16, 2025
BD MAX menu adds IVDR-certified VIASURE assays

News

Dec 16, 2025

Latest Issues

Epredia

Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...

Learn more »

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026